Genetic Testing for Men With Metastatic Prostate Cancer — GENTleMEN  

Metastatic Prostate Carcinoma Clinical Trial

Official title: GENTleMEN: Genetic Testing for Men With Metastatic Prostate Cancer

Status Active, not recruiting

Clinical Trial Summary

This research study provides genetic testing to men with prostate cancer that has spread to other parts of the body (metastatic prostate cancer) and will look for inherited genetic mutations in about 30 cancer-risk genes. The researchers seek to learn about the participant's opinions and concerns about genetic testing, to determine if this is an acceptable way to deliver testing and to potentially help guide the participant's treatment. Neither treatment nor any decisions related to treatment will take place on this study, but researchers will share each participant's genetic testing results with that participant.

Clinical Trial Description

OUTLINE: Participants receive web-based or hard-copy questionnaires and saliva collection kits via mail or in person. Participants also provide saliva samples to be mailed back to Color Genomics for genetic testing once complete. Participants then receive phone-based genetic counseling if they are identified to have an inherited mutation in a deoxyribonucleic acid (DNA) repair gene. All participants have access to phone-based genetic counseling whether or not they are not found to have a mutation. After study completion, participants are followed up at 6 months. ;

Related Conditions & MeSH terms

• Metastatic Prostate Carcinoma
• Prostatic Neoplasms
• Stage IV Prostate Cancer AJCC v8
• Stage IVB Prostate Cancer AJCC v8

• NCT number: NCT03503097
• Study type: Observational
• Source: University of Washington
• Status: Active, not recruiting
• Start date: August 21, 2017
• Completion date: August 21, 2024